The educational materials for patients and healthcare professionals included here are additional risk minimisation measures that are intended to support the safe and effective use of the medicinal product. Risk minimisation measures are a regulatory requirement and are part of the RMP (Risk Management Plans) approved by the EMA. They are assessed at national level by the HPRA for approval in Ireland.
Date of preparation: January 2025
Reference: D: GEN-IE-NP-00130 (V1.0) / T: GEN-IE-NP-00131 (V1.0) / M: GEN-IE-NP-00132 (V1.0)